NCT04827992 2025-11-05
Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain
Massachusetts General Hospital
Phase NA Completed
Clinical Trials
7 trialsNCT03948074 2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2 Completed
NCT00675948 2023-05-03
Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
Jazz Pharmaceuticals
Phase 3 Completed
NCT01337089 2023-04-12
Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Jazz Pharmaceuticals
Phase 3 Completed
NCT01361607 2023-04-12
SPRAY III
Jazz Pharmaceuticals
Phase 3 Completed
NCT01424566 2023-04-12
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
Jazz Pharmaceuticals
Phase 3 Completed
NCT03522467 2019-09-25
COPE
Aurora Cannabis Inc
Phase 2 Unknown